| Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL A Agathangelidis, A Chatzidimitriou, K Gemenetzi, V Giudicelli, ... Blood, The Journal of the American Society of Hematology 137 (10), 1365-1376, 2021 | 131 | 2021 |
| Association of Bax expression and Bcl2/Bax ratio with clinical and molecular prognostic markers in chronic lymphocytic leukemia K Vucicevic, V Jakovljevic, N Colovic, N Tosic, T Kostic, I Glumac, ... Journal of medical biochemistry 35 (2), 150, 2016 | 99* | 2016 |
| Chronic lymphocytic leukemia with mutated IGHV4-34 receptors: shared and distinct immunogenetic features and clinical outcomes A Xochelli, P Baliakas, I Kavakiotis, A Agathangelidis, LA Sutton, E Minga, ... Clinical Cancer Research 23 (17), 5292-5301, 2017 | 45 | 2017 |
| Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro M Stojiljkovic, J Jovanovic, M Djordjevic, S Grkovic, M Cvorkov Drazic, ... Clinical genetics 70 (2), 151-155, 2006 | 45 | 2006 |
| Use of Wilms tumor 1 gene expression as a reliable marker for prognosis and minimal residual disease monitoring in acute myeloid leukemia with normal karyotype patients I Marjanovic, T Karan-Djurasevic, M Ugrin, M Virijevic, A Vidovic, D Tomin, ... Clinical Lymphoma Myeloma and Leukemia 17 (5), 312-319, 2017 | 42 | 2017 |
| Gene mutation profiles in primary diffuse large B cell lymphoma of central nervous system: next generation sequencing analyses M Todorovic Balint, J Jelicic, B Mihaljevic, J Kostic, B Stanic, B Balint, ... International Journal of Molecular Sciences 17 (5), 683, 2016 | 38 | 2016 |
| Association of gene variants in TLR4 and IL-6 genes with Perthes disease S Srzentić, V Spasovski, D Spasovski, Z Živković, D Matanović, ... Srpski arhiv za celokupno lekarstvo 142 (7-8), 450-456, 2014 | 33 | 2014 |
| Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers T Karan-Djurasevic, V Palibrk, B Zukic, V Spasovski, I Glumac, M Colovic, ... Medical Oncology 30, 1-5, 2013 | 30 | 2013 |
| Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype M Virijevic, T Karan-Djurasevic, I Marjanovic, N Tosic, M Mitrovic, I Djunic, ... Radiology and Oncology 50 (4), 385, 2016 | 27 | 2016 |
| The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms V Spasovski, N Tosic, G Nikcevic, M Stojiljkovic, B Zukic, M Radmilovic, ... Journal of applied genetics 54, 21-26, 2013 | 24 | 2013 |
| Parallel targeted next generation sequencing of childhood and adult acute myeloid leukemia patients reveals uniform genomic profile of the disease I Marjanovic, J Kostic, B Stanic, N Pejanovic, B Lucic, T Karan-Djurasevic, ... Tumor Biology 37, 13391-13401, 2016 | 23 | 2016 |
| Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia T Karan-Djurasevic, V Palibrk, T Kostic, V Spasovski, G Nikcevic, ... Clinical Lymphoma Myeloma and Leukemia 12 (4), 252-260, 2012 | 22 | 2012 |
| Diagnostic and therapeutic implications of long non-coding rnas in leukemia V Gasic, T Karan-Djurasevic, D Pavlovic, B Zukic, S Pavlovic, N Tosic Life 12 (11), 1770, 2022 | 17 | 2022 |
| Novel transcriptional regulatory element in the phenylalanine hydroxylase gene intron 8 M Stojiljkovic, B Zukic, N Tosic, T Karan-Djurasevic, V Spasovski, ... Molecular genetics and metabolism 101 (1), 81-83, 2010 | 17 | 2010 |
| Thalassemia syndromes in Serbia: an update M Radmilovic, B Zukic, B Stankovic, T Karan-Djurasevic, M Stojiljkovic, ... Hemoglobin 34 (5), 477-485, 2010 | 15 | 2010 |
| Prognostic impact of NPM1 mutations in Serbian adult patients with acute myeloid leukemia M Kuzmanovic, N Tosic, N Colovic, T Karan-Djurasevic, V Spasovski, ... Acta Haematologica 128 (4), 203-212, 2012 | 13 | 2012 |
| Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier K Klaassen, M Djordjevic, A Skakic, B Kecman, R Drmanac, S Pavlovic, ... Molecular Genetics and Metabolism Reports 29, 100822, 2021 | 12 | 2021 |
| The influence of Wilms' tumor 1 gene expression level on prognosis and risk stratification of acute promyelocytic leukemia patients M Mitrovic, T Kostic, M Virijevic, T Karan‐Djurasevic, N Suvajdzic Vukovic, ... International Journal of Laboratory Hematology 42 (1), 82-87, 2020 | 12 | 2020 |
| Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling D Antic, B Mihaljevic, V Cokic, MD Fekete, TK Djurasevic, S Pavlovic, ... Leukemia & lymphoma 52 (7), 1394-1397, 2011 | 11 | 2011 |
| Thalassemia syndromes in Serbia: an update R Milena, B Zukić, B Stanković, T Karan-Đurašević, M Stojiljković, ... Hemoglobin 34 (5), 477-485, 2010 | 11 | 2010 |
